US Medicare Price Negotiation: Gaming FDA Approval Dates Could Delay Drug Selection

 
• By Cathy Kelly
  
Early February may become an extremely busy period for FDA approvals. • Source: Shutterstock

More from Market Access

More from Pink Sheet